Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says ... patients would pay less than the cash price for Eli Lilly & Co ...

Cigna's pharmacy benefits company, Evernorth, reached pricing deals with Eli Lilly and Novo Nordisk to reduce expenses and provide wider employer access to GLP-1 weight-loss treatments Wegovy and ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

Getting access to popular weight loss drugs will be simpler and cheaper for some. Evernorth, the health services division of The Cigna Group, announced the benefit that will make popular weight ...

"This solution is really focused towards clients that aren't covering it today, and what it allows us to do is one, to bring it on at a reduced price ... offering the weight loss drugs.

The median annual list price for a new drug was over $370,000 in 2024, according to the Reuters survey of 45 medicines. In 2021, the median price was $180,000 for the 30 drugs first marketed ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit management plans, the company announced on ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

The price of weight loss drugs is falling. Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose ...

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs ... a deal with drug makers Ely Lilly and Novo Nordisk which it said will bring prices down for ...

The median annual list price for a new drug was over $370,000 in 2024, according to the Reuters survey of 45 medicines. In 2021, the median price was $180,000 for the 30 drugs first marketed ...